inspection – Page 222

Non-uniform granule size during validation – CAPA and control strategy gap

Addressing Non-uniform Granule Size During Validation: Practical Solutions and CAPA Strategies Non-uniform granule size during the validation phase of pharmaceutical manufacturing can lead to serious deviations, impacting product quality and…

RMG torque fluctuation during validation – CAPA and control strategy gap

Addressing Torque Fluctuation in RMG During Equipment Validation: A Problem-Solution Guide The occurrence of torque fluctuations in a Rapid Mixer Granulator (RMG) during the validation phase is a critical concern…

Granule attrition issue during inspection readiness – CAPA and control strategy gap

Addressing Granule Attrition During Inspection Readiness: A Practical Guide to CAPA and Control Strategies Granule attrition is a critical issue often identified during inspection readiness assessments in pharmaceutical manufacturing. This…

Inadequate end-point detection during drying phase – process vs equipment root cause

Addressing Inadequate End-Point Detection in the Drying Phase of Pharmaceutical Manufacturing Inadequate end-point detection during the drying phase of pharmaceutical production can lead to significant inefficiencies, compromised product quality, and…

Over-wetting observed after scale-up – inspection risk analysis

Assessing the Risk of Over-wetting After Scale-Up in Pharmaceutical Manufacturing In pharmaceutical manufacturing, particularly during scale-up of granulation processes, the phenomenon of over-wetting can have serious implications for product quality…

Non-uniform granule size during wet granulation – inspection risk analysis

Addressing Non-uniform Granule Size During Wet Granulation: An Inspection Risk Analysis In pharmaceutical manufacturing, achieving a uniform granule size during the wet granulation process is critical to ensure the efficacy…

Granule attrition issue after scale-up – process vs equipment root cause

Addressing Granule Attrition Challenges Post Scale-Up: A Practical Approach In the pharmaceutical manufacturing landscape, the transition from small-scale to large-scale production often uncovers various challenges, notably granule attrition. This issue…

Inadequate end-point detection during inspection readiness – CAPA and control strategy gap

“`html Addressing Insufficient End-Point Detection for Inspection Readiness: Gaps in CAPA and Control Strategy In pharmaceutical manufacturing, a consistent and reliable end-point detection mechanism is crucial for ensuring quality and…

Granule attrition issue during drying phase – inspection risk analysis

Managing Granule Attrition Issues During the Drying Phase: An Effective Workflow Granule attrition during the drying phase is a critical issue that can lead to non-compliance, increased rejection rates, and…

Binder spray nozzle blockage after scale-up – inspection risk analysis

Addressing Binder Spray Nozzle Blockage Post Scale-Up: An Inspection Risk Analysis Binder spray nozzle blockage after scale-up is a prevalent issue in pharmaceutical manufacturing that can lead to significant production…

Over-wetting observed during validation – process vs equipment root cause

Addressing Over-wetting Issues During Validation: Equipment Versus Process Root Causes Over-wetting during validation, especially in granulation processes, can signify underlying equipment or process failures. This absorption problem not only undermines…

Over-wetting observed during validation – inspection risk analysis

Analyzing Over-Wetting Issues During Validation: Strategies for Compliance and Quality Assurance Over-wetting during equipment validation is a critical failure signal that can jeopardize product quality and lead to significant compliance…